510(k) Report

510(k) · Cleared

Cleared

SmartCT R1.0

K201583510(k) AbbreviatedCleared Feb 9, 2021243-day reviewClass II21 CFR 892.1650

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Philips Medical Systems Nederland B.V. · OWB Interventional Fluoroscopic X-Ray System

Cleared on Feb 9, 2021 as substantially equivalent to K130893 (Philips Medical Systems Nederland B.V., 2013) and 1 other predicate after a 243-day review. Its family tree reaches back 6 generations to 1991. 1 later device descends from it.

Decided
Feb 9, 2021
Review
243 days
Class
Class II
Product code
OWB
Recalls
None
Predicates
2

Its longest line of descent runs back 6 generations to K913770 (1991). 20 ancestors in all, the oldest K852353 (1985). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2013: 1 other ancestor2006: 1 other ancestor2004: 3 other ancestors1998: 2 other ancestors1985: 1 other ancestor2001: 1 other ancestor1997: 1 other ancestor1995: 1 other ancestor1993: 1 other ancestor1987: 1 other ancestor1994: 1 other ancestor2026: 1 descendant clearedK913770 · Advantage V.S. CT/MR Rad Diagnostic Workstation · General Electric Co. · 1991K960613 · GE Advantage Windows Review Workstation · GE Medical Systems · 1996K020483 · Advantage Workstation 4.1 · GE Medical Systems · 2002 · recalledK052995 · Advantage Workstation 4.3. · GE Healthcare · 2005 · recalledK092639 · Innova Vision, Model S18751VN, Innova Trackvision, Model S18751VT, Innova Epvision, Model S18751EP · GE Medical Systems SCS · 2009K121772 · Allura 3D-RA Rel 6, 3D Roadmap Rel 1, MR-CT Roadmap Rel 1 · Philips Medical Systems Nederland B.V. · 20131990200020102020
  1. Root · 6 generations backK913770 Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co. · 1991
  2. 5 generations backK960613 GE Advantage Windows Review WorkstationGE Medical Systems · 1996
  3. 4 generations backK020483 Advantage Workstation 4.1GE Medical Systems · 2002 · Recalled
  4. 3 generations backK052995 Advantage Workstation 4.3.GE Healthcare · 2005 · Recalled
  5. 2 generations backK092639 Innova Vision, Model S18751VN, Innova Trackvision, Model S18751VT…GE Medical Systems SCS · 2009
  6. 1 generation backK121772 Allura 3D-RA Rel 6, 3D Roadmap Rel 1, MR-CT Roadmap Rel 1Philips Medical Systems Nederland B.V. · 2013
  7. This deviceK201583 SmartCT R1.0Philips Medical Systems Nederland B.V. · 2021
  8. Descendant · cites it directly · 0 of its ownK253670 SmartCT (R3.0 (L10))Philips Medical Systems B.V. · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K253670SmartCT (R3.0 (L10))Philips Medical Systems B.V. · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K913770Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co.1991—
−5K960613GE Advantage Windows Review WorkstationGE Medical Systems1996—
−4K020483Advantage Workstation 4.1GE Medical Systems20022
−3K052995Advantage Workstation 4.3.GE Healthcare20054
−2K092639Innova Vision, Model S18751VN, Innova Trackvision, Model S18751VT, Innova…GE Medical Systems SCS2009—
−1K121772Allura 3D-RA Rel 6, 3D Roadmap Rel 1, MR-CT Roadmap Rel 1Philips Medical Systems Nederland B.V.2013—
0 (this device)K201583SmartCT R1.0Philips Medical Systems Nederland B.V.2021—
+1K253670SmartCT (R3.0 (L10))Philips Medical Systems B.V.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198510
198710
199310
199410
199510
199710
199820
200110
200430
200610
201310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K201583, 1991–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OWB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OWB device

  1. #1 K251602 Alphenix, INFX-8000V/B, INFX-8000V/S, V9.6…score 18.3 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K130893Xperct Rel. 3
Summary page 5
…XperCT Device: Manufacturer: Philips Medical Systems Nederland B.V. 510(k) Clearance: K130893 (September 6, 2013) Classification Name: Interventional fluoroscopic x-ray system…
Philips Medical Systems Nederland B.V.2013—
*K121772Allura 3D-RA Rel 6, 3D Roadmap Rel 1, MR-CT Roadmap Rel 1
Summary page 6
…Allura 3D-RA Devices: Manufacturer: Philips Medical Systems Nederland B.V. 510(k) Clearance: K121772 (March 21, 2013) Classification Name: Interventional fluoroscopic x-ray system…
Philips Medical Systems Nederland B.V.2013—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K253670SmartCT (R3.0 (L10))Philips Medical Systems B.V.20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 30 years and passes through 5 companies; a new generation was cleared every 4.3 years on median.
  • 6 of the 20 ancestors have a recall of any class.
  • Of its descendants, K253670 (Philips Medical Systems B.V., 2026) has gone furthest, with 0 descendants of its own.

How does its category compare?

All OWB devices

OWB Interventional Fluoroscopic X-Ray System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · OWB

22in 2025

2007: 32008: 42009: 92010: 72011: 62012: 62013: 112014: 152015: 112016: 162017: 202018: 232019: 92020: 162021: 242022: 212023: 122024: 132025: 222026 (partial year): 15
2007high 24 (2021) · low 3 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OWB

148in 2025

2007: 52 days median2008: 135 days median2009: 99 days median2010: 66 days median2011: 79 days median2012: 37 days median2013: 119 days median2014: 158 days median2015: 66 days median2016: 103 days median2017: 76 days median2018: 54 days median2019: 174 days median2020: 53 days median2021: 60 days median2022: 90 days median2023: 152 days median2024: 126 days median2025: 148 days median2026 (partial year): 221 days median
2007high 221 (2026) · low 37 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OWB

42so far in 2026, the most since 2007

2008: 12013: 102014: 92015: 352016: 132017: 132018: 62019: 72020: 82021: 312022: 242023: 222024: 112025: 302026 (partial year): 42
2007high 42 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OWB

14,008in 2025

2007: 12011: 12012: 12013: 272014: 1032015: 2,1342016: 4,0742017: 1,6042018: 1,4492019: 1,5582020: 1,5812021: 1,9812022: 2,9322023: 7,6042024: 7,9422025: 14,008
2007high 14,008 (2025) · low 0 (2008)2025

MAUDE reports naming product code OWB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735201
2008413510
200999900
201076600
201167901
201263701
2013111191027
2014151589103
20151166352,134
201616103134,074
20172076131,604
2018235461,449
2019917471,558
2020165381,581
20212460311,981
20222190242,932
202312152227,604
202413126117,942
2025221483014,008
20261522142—

What is it indicated for?

SmartCT assists physicians during vascular and non-vascular procedures, with diagnosis, treatment planning, interventional procedures and treatment follow-up by creating 3D views from sets of 2D images created during rotational acquisitions. SmartCT provides high-speed and high-resolution 3D visualizations of vasculature, hemorrhages, soft tissue and bone structures. SmartCT provides live image guidance for navigating endovascular devices through…

Read the full statement (110 words)

SmartCT assists physicians during vascular and non-vascular procedures, with diagnosis, treatment planning, interventional procedures and treatment follow-up by creating 3D views from sets of 2D images created during rotational acquisitions.

SmartCT provides high-speed and high-resolution 3D visualizations of vasculature, hemorrhages, soft tissue and bone structures.

SmartCT provides live image guidance for navigating endovascular devices through vascular structures anywhere in the body.

SmartCT helps to assess anatomical information intra-procedurally, such as the estimate of a vessel or lesion size, diameter or volume, and anatomical distances between relevant structures.

SmartCT is intended to be used for human patients that have been elected for the procedures as described in the Indications for Use.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K201583: SmartCT R1.0.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K201583

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026